Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Pharma Warns On O'Neill Levy Idea But Wants To Join Global AMR Fight

Executive Summary

The drugs industry has slammed the O'Neill AMR Review's proposal that pharma pays for a big part of the bill for tackling antimicrobial resistance – warning it could delay a solution and illustrating how difficult it might be to forge the collective worldwide response that the report calls for.

Advertisement

Related Content

Pharma's Latest Davos Pledge: Sincere, Or Just Keeping Up Appearances?

Topics

Advertisement
UsernamePublicRestriction

Register

SC065244

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel